Intimation of Conference Call for Analysts and Investors

Ref: Syn/CS/SE/Reg 30/2026-27/Oct/04 Syngene International Limited Biocon SEZ, Biocon Park, Plot No. 2 & 3, Bommasandra Industrial Area, IV Phase, Jigani Link Road, Bengaluru 560 099, Karnataka, India T +91 80 6891 9191 CIN: L85110KA1993PLC014937 October 17, 2026 www.syngeneintl.com To, To, The Manager, The Manager, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Corporate Communication Department Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051 Scrip Code: 539268 Scrip Symbol: SYNGENE Dear Sir/Madam, Subject: Intimation of Conference Call for Analysts and Investors Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for the conference call for Analysts and Investors to be held on Wednesday, October 28, 2026. The above-mentioned information will also be available on the website of the Company www.syngeneintl.com. Request to kindly take this intimation on record. Thanking you, Yours faithfully, For SYNGENE INTERNATIONAL LIMITED Chethan Yogesh Company Secretary & Compliance Officer INVESTOR CONFERENCE CALL INVITE Q2 FY 2026-27 Syngene’s Q2 FY2027 Results Conference Call At 9:00 AM IST on 28th October 2026 The management team of Syngene International Limited (BSE code: 539268, NSE ID: SYNGENE) will organize a conference call for Analysts and Investors following the announcement of financial results for the quarter ended September 30th, 2026. The call will be conducted over Zoom. Conference Call Details Date Wednesday, 28th October 2026 Time 9:00 am to 10:00 am IST Registration Link Click here Recording Audio recording will be made available before the next trading day or within 24 hrs from the end of the call, whichever is earlier, on the corporate website: (Syngene > Investors > Financial Information) Conference Call Transcript Will be made available within 7 working days of the conclusion of the call on the Company website (Syngene > Investors > Financial Information) *Participants are requested to join 10 minutes before the scheduled start time of the call. For further information, please contact: Soudabi Neduvanchery / Ankush Balani M: +91 9686916863 / 9163183180 E: soudabi.neduvanchery1@syngeneintl.com E: ankush.balani@syngeneintl.com Disclaimer: Certain of the statements that may be made or discussed at the conference call may be forward-looking statements and/or based on management's current expectations and beliefs concerning future developments and their potential effects upon Syngene International Limited (Syngene) and its associates. There can be no assurance that future developments affecting Syngene, and its associates will be those anticipated by management. These forward-looking statements are not a guarantee of future performance and involve risks and uncertainties and there are important factors that could cause actual results to differ, possibly materially, from expectations reflected in such forward-looking statements. Syngene does not intend, and is under no obligation, to update any forward-looking statement made at the conference call. Syngene International: Putting Science to Work